| Product Code: ETC9689838 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Myelodysplastic Syndromes (MDS) Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Myelodysplastic Syndromes (MDS) Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Myelodysplastic Syndromes (MDS) Market - Industry Life Cycle |
3.4 Thailand Myelodysplastic Syndromes (MDS) Market - Porter's Five Forces |
3.5 Thailand Myelodysplastic Syndromes (MDS) Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Thailand Myelodysplastic Syndromes (MDS) Market Revenues & Volume Share, By Therapeutic Class, 2021 & 2031F |
3.7 Thailand Myelodysplastic Syndromes (MDS) Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.8 Thailand Myelodysplastic Syndromes (MDS) Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Thailand Myelodysplastic Syndromes (MDS) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of myelodysplastic syndromes (MDS) in Thailand |
4.2.2 Growing awareness and diagnosis rates of MDS in the country |
4.2.3 Technological advancements in MDS treatment options |
4.3 Market Restraints |
4.3.1 High treatment costs associated with MDS therapies |
4.3.2 Limited access to specialized healthcare facilities for MDS treatment in certain regions of Thailand |
5 Thailand Myelodysplastic Syndromes (MDS) Market Trends |
6 Thailand Myelodysplastic Syndromes (MDS) Market, By Types |
6.1 Thailand Myelodysplastic Syndromes (MDS) Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Thailand Myelodysplastic Syndromes (MDS) Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Thailand Myelodysplastic Syndromes (MDS) Market Revenues & Volume, By Myelodysplastic Syndrome with Unilineage Dysplasia, 2021- 2031F |
6.1.4 Thailand Myelodysplastic Syndromes (MDS) Market Revenues & Volume, By Myelodysplastic Syndrome with Multilineage Dysplasia, 2021- 2031F |
6.1.5 Thailand Myelodysplastic Syndromes (MDS) Market Revenues & Volume, By Myelodysplastic Syndrome with Ring Sideroblasts, 2021- 2031F |
6.1.6 Thailand Myelodysplastic Syndromes (MDS) Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Thailand Myelodysplastic Syndromes (MDS) Market, By Therapeutic Class |
6.2.1 Overview and Analysis |
6.2.2 Thailand Myelodysplastic Syndromes (MDS) Market Revenues & Volume, By Hypomethylating Agents, 2021- 2031F |
6.2.3 Thailand Myelodysplastic Syndromes (MDS) Market Revenues & Volume, By Immunomodulatory Drugs, 2021- 2031F |
6.2.4 Thailand Myelodysplastic Syndromes (MDS) Market Revenues & Volume, By Anti-anemics, 2021- 2031F |
6.3 Thailand Myelodysplastic Syndromes (MDS) Market, By Treatment |
6.3.1 Overview and Analysis |
6.3.2 Thailand Myelodysplastic Syndromes (MDS) Market Revenues & Volume, By Supportive Therapy, 2021- 2031F |
6.3.3 Thailand Myelodysplastic Syndromes (MDS) Market Revenues & Volume, By Growth Factors, 2021- 2031F |
6.3.4 Thailand Myelodysplastic Syndromes (MDS) Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.3.5 Thailand Myelodysplastic Syndromes (MDS) Market Revenues & Volume, By Stem Cell Transplant, 2021- 2031F |
6.3.6 Thailand Myelodysplastic Syndromes (MDS) Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Thailand Myelodysplastic Syndromes (MDS) Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Thailand Myelodysplastic Syndromes (MDS) Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 Thailand Myelodysplastic Syndromes (MDS) Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.4.4 Thailand Myelodysplastic Syndromes (MDS) Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Thailand Myelodysplastic Syndromes (MDS) Market Import-Export Trade Statistics |
7.1 Thailand Myelodysplastic Syndromes (MDS) Market Export to Major Countries |
7.2 Thailand Myelodysplastic Syndromes (MDS) Market Imports from Major Countries |
8 Thailand Myelodysplastic Syndromes (MDS) Market Key Performance Indicators |
8.1 Average age of MDS diagnosis in Thailand |
8.2 Number of healthcare professionals specializing in MDS treatment |
8.3 Percentage of MDS patients receiving timely and appropriate treatment |
8.4 Research and development investment in innovative MDS therapies |
8.5 Patient satisfaction with MDS treatment options and healthcare services |
9 Thailand Myelodysplastic Syndromes (MDS) Market - Opportunity Assessment |
9.1 Thailand Myelodysplastic Syndromes (MDS) Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Thailand Myelodysplastic Syndromes (MDS) Market Opportunity Assessment, By Therapeutic Class, 2021 & 2031F |
9.3 Thailand Myelodysplastic Syndromes (MDS) Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.4 Thailand Myelodysplastic Syndromes (MDS) Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Thailand Myelodysplastic Syndromes (MDS) Market - Competitive Landscape |
10.1 Thailand Myelodysplastic Syndromes (MDS) Market Revenue Share, By Companies, 2024 |
10.2 Thailand Myelodysplastic Syndromes (MDS) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here